Metabolism of a novel nucleoside analogue, OGT 719, in the isolated perfused rat liver model, in rats, in tumour models and in patients

References

• ARELLANO, M., MALET-MARTINO, M., MARTINO, R. and SPECTOR, T., 1997, 5-ethynyluracil (GW776): effects on the formation of the toxic catabolites of 5-fluorouracil, fluoroacetate and fluorohydroxypropionic acid in the isolated perfused rat liver model. British Journal of Cancer, 76, 1170–1180.
   Google Scholar
• ASHWELL, G. and MORELL, A. G., 1974, The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Advances in Enzymology and Related Areas of Molecular Biology, 41, 99–128.
   PubMedGoogle Scholar
• BERRY, J. P., CHAINTREAU, M., CHASSOUX, D., DENNEBOUY, R., ESCAIG, F., CALLE, P., ROSSIGNOL, J. M., SLODZIAN, G. and TwuzEAu, S., 1994, Advantages of the scanning ion microscopy for mapping halogen corticoids in normal and transformed cells in culture. Biology of the Cell, 81, 65–72.
   PubMedGoogle Scholar
• CASTLE, M. C., 1993, Formation of a 13-glucuronidase-resistant glucuronide conjugate of digitoxin by dog liver micro somes. Drug Metabolism and Disposition, 21, 1147–1150.
   PubMedGoogle Scholar
• DEAR, G. J., IsmAIL, I. M., MUTCH, P. J., PLUMB, R .S., DAVIES, L. H. and SWEATMAN, B. C., 2000, Urinary metabolites of a novel quinoxaline non-nucleoside reverse transcriptase inhibitor in rabbit, mouse and human: identification of fluorine NIH shift metabolites using NMR and tandem MS. Xenobiotica, 30, 407–426.
   PubMed Web of Science ®Google Scholar
• FEOFANOV, A., CHARONOV, S., FLEURY, F., KUDELINA, I., JARDILLIER, J. C. and NABIEV, I., 1999, Confocal spectral imaging analysis of intracellular interactions of mitoxantrone at different phases of the cell cycle. Anticancer Research, 19, 5341–5348.
   PubMedGoogle Scholar
• IsmAiL, I. M., DEAR, G. J., ROBERTS, A. D., PLUMB, R. S., AYRTONT, J., SWEATMAN, B. C. and BOWERS, G. D., 2002, N-0 glucuronidation: a major human metabolic pathway in the elimination of two novel anti-convulsant drug candidates. Xenobiotica, 32, 29–43.
   PubMed Web of Science ®Google Scholar
• LODISH, H. F., 1991, Recognition of complex oligosaccharides by the multi-subunit asialoglycoprotein receptor. Trends in Biochemical Sciences, 16, 374–377.
   PubMedGoogle Scholar
• MALET-MARTINO, M. C., ARMAND, J. P., LOPEZ, A., BERNADOU, J., BETEILLE, J. P., BON, M. and MARTINO, R., 1986, Evidence for the importance of 5'-deoxy-5-fluorouridine catabolism in humans from 19F nuclear magnetic resonance spectrometry. Cancer Research, 46, 2105–2112.
   Google Scholar
• MALET-MARTINO, M. C. and MARTINO, R., 1992, Magnetic resonance spectroscopy: a powerful tool for drug metabolism studies. Biochimie, 74, 785–800.
   Google Scholar
• MARTINO, R., MALET-MARTINO, M. and GILARD, V., 2000, Fluorine nuclear magnetic resonance, a privileged tool for metabolic studies of fiuoropyrimidine drugs. Current Drug Metabolism, 1, 271–303.
   Google Scholar
• MARTINO, R., MALET-MARTINO, M. C., VIALANEIX, C., LOPEZ, A. and BON, M., 1987, 19F nuclear magnetic resonance analysis of the carbamate reaction of cc-fluoro-13-alanine (FBAL), the major catabolite of fiuoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine. Drug Metabolosm and Disposition, 15, 897–904.
   Google Scholar
• Mu, J. Z., GORDON, M., SHAO, J. S. and ALPERS, D. H., 1997, Apical expression of functional asialoglycoprotein receptor in the human intestinal cell line HT-29. Gastroenterology, 113, 1501–1509.
   PubMed Web of Science ®Google Scholar
• NAKABAYASHI, H., TAKETA, K., MIYANO, K., YAMANE, T. and SATO, J., 1982, Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Research, 42, 3858–3863.
   PubMed Web of Science ®Google Scholar
• PARISOT, D., MALET-MARTINO, M. C., MARTINO, R. and CRASNIER, P., 1991, 19F nuclear magnetic resonance analysis of 5-fluorouracil metabolism in four differently pigmented strains of Nectria haematococca. Applied and Environmental Microbiology, 57, 3605–3612.
   Google Scholar
• PINEDO, H. M. and PETERS, G. J., 1988, Fluorouracil: biochemistry and pharmacology. Journal of Clinical Oncology, 6, 1653–1664.
   Google Scholar
• ROBERTS, A., RENWICK, A. G., Sims, J. and SNODIN, D. J., 2000, Sucralose metabolism and pharmacokinetics in man. Food Chemistry and Toxicology, 38 (Suppl. 2), S31—S41.
   Google Scholar
• ROHLFF, C., HOLT, G., COURTNEY, S. and TREPEL, J., 1997, Enhanced liver specific activity of a glycan-conjugated 5-FU for the treatment of hepatocellular cancer. Proceedings of the American Association for Cancer Research, 38, abst 698.
   Google Scholar
• ROHLFF, C., WATSON, S. A., MORRIS, T. M., SKELTON, L., JACKMAN, A. L. and PAGE, M. J., 1999, A novel, orally administered nucleoside analogue, OGT 719, inhibits the liver invasive growth of a human colorectal tumor, C17OHM2. Cancer Research, 59, 1268–1272.
   PubMed Web of Science ®Google Scholar
• SCARFE, G. B., WRIGHT, B., CLAYTON, E., TAYLOR, S., WILSON, I. D., LINDON, J. C. and NICHOLSON, J. K., 1999, Quantitative studies on the urinary metabolic fate of 2-chloro-4-trifluoromethylani-line in the rat using 19F-NMR spectroscopy and directly coupled HPLC-NMR-MS. Xenobiotica, 29, 77–91.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ, A. L., FRIDOVICH, S. E., KNOWLES, B. B. and LODISH, H. F., 1981, Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. Journal of Biological Chemistry, 256, 8878–8881.
   PubMed Web of Science ®Google Scholar
• SHARMA, R. A., EATOCK, M. M., TWELVES, C. J., BROWN, G., MCLELLAND, H. R., CLAYTON, K. T., O'BYRNE, K. J., MOYSES, C., CARMICHAEL, J. and STEWARD, W. P., 2001, Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver. Cancer Chemotherapy and Pharmacology, 48, 197–201.
   Google Scholar
• WAIN, W. H. and STAATZ, W. D., 1973, Rates of synthesis of ribosomal protein and total ribonucleic acid through the cell cycle of the fission yeast Schizosaccharomyces pombe. Experimental Cell Research, 81, 269–278.
   PubMedGoogle Scholar
• WEISS, P. and ASHWELL, G., 1989, The asialoglycoprotein receptor: properties and modulation by ligand. Progress in Clinical Biology Research, 300, 169–184.
   PubMedGoogle Scholar
• WOOD, S. G., JOHN, B. A. and HAWKINS, D. R., 2000, The pharmacokinetics and metabolism of sucralose in the dog. Food and Chemical Toxicology, 38 (Suppl. 2), S99–5106.
   PubMed Web of Science ®Google Scholar